These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 10219525

  • 1. Evaluation of rapidly disintegrating tablets prepared by a direct compression method.
    Bi YX, Sunada H, Yonezawa Y, Danjo K.
    Drug Dev Ind Pharm; 1999 May; 25(5):571-81. PubMed ID: 10219525
    [Abstract] [Full Text] [Related]

  • 2. [Formulation optimization of panax notoginsenoside orally fast disintegration tablets].
    Wang Z, Wei L, Chen T.
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1676-80. PubMed ID: 18841763
    [Abstract] [Full Text] [Related]

  • 3. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA.
    Int J Pharm; 2016 Mar 30; 501(1-2):87-95. PubMed ID: 26827922
    [Abstract] [Full Text] [Related]

  • 4. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
    Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T.
    Chem Pharm Bull (Tokyo); 2006 Feb 30; 54(2):175-80. PubMed ID: 16462059
    [Abstract] [Full Text] [Related]

  • 5. The preparation of rapidly disintegrating tablets in the mouth.
    Sugimoto M, Matsubara K, Koida Y, Kobayashi M.
    Pharm Dev Technol; 2001 Nov 30; 6(4):487-93. PubMed ID: 11775950
    [Abstract] [Full Text] [Related]

  • 6. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E, Antal B, Zsadon B, Szejtli J.
    Pharmazie; 1984 Jul 30; 39(7):473-5. PubMed ID: 6494226
    [Abstract] [Full Text] [Related]

  • 7. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K.
    Chem Pharm Bull (Tokyo); 1996 Nov 30; 44(11):2121-7. PubMed ID: 8945778
    [Abstract] [Full Text] [Related]

  • 8. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.
    Shimizu T, Sugaya M, Nakano Y, Izutsu D, Mizukami Y, Okochi K, Tabata T, Hamaguchi N, Igari Y.
    Chem Pharm Bull (Tokyo); 2003 Oct 30; 51(10):1121-7. PubMed ID: 14519914
    [Abstract] [Full Text] [Related]

  • 9. Predictive model for tensile strength of pharmaceutical tablets based on local hardness measurements.
    Juban A, Nouguier-Lehon C, Briancon S, Hoc T, Puel F.
    Int J Pharm; 2015 Jul 25; 490(1-2):438-45. PubMed ID: 26043825
    [Abstract] [Full Text] [Related]

  • 10. Tensile strength and disintegration of tableted silicified microcrystalline cellulose: influences of interparticle bonding.
    Kachrimanis K, Nikolakakis I, Malamataris S.
    J Pharm Sci; 2003 Jul 25; 92(7):1489-501. PubMed ID: 12820153
    [Abstract] [Full Text] [Related]

  • 11. Prediction of tablet characteristics from residual stress distribution estimated by the finite element method.
    Hayashi Y, Miura T, Shimada T, Onuki Y, Obata Y, Takayama K.
    J Pharm Sci; 2013 Oct 25; 102(10):3678-86. PubMed ID: 23897300
    [Abstract] [Full Text] [Related]

  • 12. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S, Fukai T, Sakamoto T.
    AAPS PharmSciTech; 2021 Dec 23; 23(1):37. PubMed ID: 34950985
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose.
    Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H.
    Int J Pharm; 2005 May 30; 296(1-2):64-72. PubMed ID: 15885456
    [Abstract] [Full Text] [Related]

  • 14. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
    Ishikawa T, Mukai B, Shiraishi S, Utoguchi N, Fujii M, Matsumoto M, Watanabe Y.
    Chem Pharm Bull (Tokyo); 2001 Feb 30; 49(2):134-9. PubMed ID: 11217097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.